In summary, acetylharpagide protects mice from S. aureus-induced pneumonia and lung injury by suppressing NF-κB signaling pathways and acetylharpagide is expected to become a potential treatment for S. aureus-induced ALI. The gene discussed is NFKB1; the disease is susceptibility to pneumonia measurement.